Peng Zhou

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Cardiovascular Disease

Top Venues

Inflammopharmacology

Evidence-based complementary and alternative medicine : eCAM

The Journal of pharmacy and pharmacology

Journal of food biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ya-Li Yang, Chuan-Zhi Zhao, Chun-Chun Zhao, Zhong-Yu Wen, Yao-Yao Ma, Xiao-Ni Zhao, Liang Wang, Jin-Ling Huang, Peng Zhou
Ling-Gui-Zhu-Gan decoction protects against doxorubicin-induced myocardial injury by downregulating ferroptosis. The Journal of pharmacy and pharmacology (2024)
Ya-Li Yang, Chuan-Zhi Zhao, Chun-Chun Zhao, Zhong-Yu Wen, Yao-Yao Ma, Xiao-Ni Zhao, Liang Wang, Jin-Ling Huang, Peng Zhou
Ling-Gui-Zhu-Gan decoction protects against doxorubicin-induced myocardial injury by downregulating ferroptosis. The Journal of pharmacy and pharmacology 76 (4) (2024)
Peng Zhou, Yao-Yao Ma, Xiao-Ni Zhao, Fang Hua
Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases. Inflammopharmacology 31 (1) (2023)
Meng Zhang, Zhi-Xian Ding, Wei Huang, Jing Luo, Shu Ye, Sheng-Lin Hu, Peng Zhou, Biao Cai
Chrysophanol exerts a protective effect against Aβ 25-35 -induced Alzheimer's disease model through regulating the ROS/TXNIP/NLRP3 pathway. Inflammopharmacology (2023)
Peng Zhou, Yao-Yao Ma, Xiao-Ni Zhao, Fang Hua
Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases. Inflammopharmacology (2023)
Peng Zhou, Yao-Yao Ma, Xiao-Ni Zhao, Fang Hua
Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases. Inflammopharmacology 31 (1) (2023)
Hai-Yan Fang, Xiao-Ni Zhao, Meng Zhang, Yao-Yao Ma, Jin-Ling Huang, Peng Zhou
Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome. Inflammopharmacology (2023)
Peng Zhou, Yao-Yao Ma, Xiao-Ni Zhao, Fang Hua
Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases. Inflammopharmacology 31 (1) (2023)
Jiajia Mo, Peng Zhou, Zhaoxing Chu, Yan Zhao, Xiang Wang
Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Jing-Ya Li, Chun-Chun Zhao, Jian-Fei Peng, Meng Zhang, Liang Wang, Gang Yin, Peng Zhou
The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Fang Hua, Peng Zhou, Guan-Hu Bao, Tie-Jun Ling
Flavonoids in Lu'an GuaPian tea as potential inhibitors of TMA-lyase in acute myocardial infarction. Journal of food biochemistry 46 (7) (2022)
Jing-Ya Li, Chun-Chun Zhao, Jian-Fei Peng, Meng Zhang, Liang Wang, Gang Yin, Peng Zhou
The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Meng-Yu Zuo, Tong-Juan Tang, Xiang Wang, Jin-Fan Gu, Liang Wang, Jian Chen, Juan Yao, Xiang-Yang Li, Peng Zhou, Jin-Ling Huang
Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Fang Hua, Lingli Shi, Peng Zhou
Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases. Inflammopharmacology 30 (1) (2022)
Peng Zhou, Meng Zhang, Xiao-Ni Zhao, Tong-Juan Tang, Xiang Wang, Lu-Lu Huang, Qi Kong, Liang Wang, Jin-Ling Huang
Exploring the Mechanism of Ling-Gui-Zhu-Gan Decoction in Ventricular Remodeling after Acute Myocardial Infarction Based on UPLC and In Vivo Experiments. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Meng Zhang, Guanhua Hu, Nan Shao, Yunpeng Qin, Qian Chen, Yan Wang, Peng Zhou, Biao Cai
Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols. Inflammopharmacology 29 (5) (2021)
Hui Shi, Peng Zhou, Ge Gao, Pei-Pei Liu, Shu-Shu Wang, Rui Song, Ying-Ying Zou, Gang Yin, Liang Wang
Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Journal of food biochemistry 45 (7) (2021)
Peng Zhou, Fang Hua, Xiang Wang, Jin-Ling Huang
Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases. Inflammopharmacology 28 (1) (2020)
Da-Bao Chen, Hua-Wu Gao, Cheng Peng, Shao-Qiang Pei, An-Ran Dai, Xue-Ting Yu, Peng Zhou, Yan Wang, Biao Cai
Quinones as preventive agents in Alzheimer's diseases: focus on NLRP3 inflammasomes. The Journal of pharmacy and pharmacology 72 (11) (2020)
Xiang Wang, Tongjuan Tang, Mengting Zhai, Ruirui Ge, Liang Wang, Jin-Ling Huang, Peng Zhou
Ling-Gui-Zhu-Gan Decoction Protects H9c2 Cells against H2O2-Induced Oxidative Injury via Regulation of the Nrf2/Keap1/HO-1 Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
Shu Ye, Biao Cai, Peng Zhou, Guoquan Wang, Huawu Gao, Rupeng Hua, Liangzhen You, Yongchuan Yao, Yan Wang, Guo-Ming Shen
Huang-Pu-Tong-Qiao Formula Ameliorates Tau Phosphorylation by Inhibiting the CaM-CaMKIV Pathway. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
Peng Zhou, Jinling Huang, Wanxue Ding
Effect of Ling-Gui-Zhu-Gan decoction major components on the plasma protein binding of metoprolol using UPLC analysis coupled with ultrafiltration. RSC advances 8 (63) (2018)